HSA — authorised 27 November 2013
- Marketing authorisation holder: VIFOR FRESENIUS
- Status: likely_approved
🇸🇬 Ferrlecit in Singapore
HSA authorised Ferrlecit on 27 November 2013
Marketing authorisation
Ferrlecit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Singapore
Frequently asked questions
Is Ferrlecit approved in Singapore?
Yes. HSA authorised it on 27 November 2013.
Who is the marketing authorisation holder for Ferrlecit in Singapore?
VIFOR FRESENIUS holds the Singaporean marketing authorisation.